Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026
2 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Alamar Biosciences, Inc.’s names, not what it holds today.
Patents granted
2
2 utility, 1976 to Dec 31, 2025
Granted in 2025
1
Against 1 in 2024 and none in 2023
Applications published
8
5 of them in 2025
Names they are printed under
2
its own name
By yearGrantedApplications published
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name2 counted
Alamar Biosciences, Inc. its own name
named as the applicant on its applications, in US
7 publishedAlamar Biosciences, Inc. its own name
US, as the owner printed on each patent
1 published
Newest grantseach row opens the USPTO’s own copy
Newest applications publishedan application is a clue, never a plan
| Published | Application | Title | Field | Owner as printed |
|---|
| Nov 6, 2025 | 2025/0341533 | Fully Automatic Instrument System for Biochemical Assays | Measurement | Alamar Biosciences, Inc. |
| Oct 2, 2025 | 2025/0306045 | Fully Automatic Instrument System for Biochemical Assays | Measurement | Alamar Biosciences, Inc. |
| Jun 19, 2025 | 2025/0199010 | BINDER MOLECULES WITH HIGH AFFINITY AND/ OR SPECIFICITY AND METHODS OF MAKING AND USE THEREOF | Biotechnology | Alamar Biosciences, Inc. |
| May 1, 2025 | 2025/0138000 | NUCLEIC ACID LINKED IMMUNE-SANDWICH ASSAY (NULISA) | Biotechnology | Alamar Biosciences, Inc. |
| Feb 6, 2025 | 2025/0044310 | Fully Automatic Instrument System for Biochemical Assays | Measurement | Alamar Biosciences, Inc. |
| Dec 8, 2022 | 2022/0390442 | NUCLEIC ACID LINKED IMMUNE-SANDWICH ASSAY (NULISA) | Analysis of biological materials | Alamar Biosciences, Inc. |
| Sep 16, 2021 | 2021/0285941 | NUCLEIC ACID LINKED IMMUNE-SANDWICH ASSAY (NULISA) | Biotechnology | Alamar Biosciences, Inc. · patent 12,188,929 granted from it |
| Sep 9, 2021 | 2021/0278398 | NUCLEIC ACID LINKED IMMUNE-SANDWICH ASSAY (NULISA) | Biotechnology | Alamar Biosciences, Inc. · patent 12,105,084 granted from it |
What it applied for, 2024 to 2025: Measurement 3 · Biotechnology 2.
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.